Top Markets
Coin of the day
Merck & Co., Inc. Merck & Co., Inc.

Merck & Co., Inc.

MRK
주식 순위 #40
Merck & Co., Inc. is a global healthcare leader with operations spanning two... Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This division also develops vital preventive vaccines for pediatric, adolescent, and adult populations. Meanwhile, the Animal Health segment focuses on the research, development, manufacturing, and marketing of veterinary medications, vaccines, and comprehensive health management solutions for animals. This division further provides innovative digital products designed for animal identification, traceability, and continuous monitoring. Merck's extensive clientele encompasses drug wholesalers, pharmacies, hospitals, and government agencies. It also serves managed healthcare organizations, including health maintenance organizations (HMOs) and pharmacy benefit managers, as well as various other institutional clients. Additionally, the company supplies products to individual physicians and their distributors, veterinarians, and livestock producers. The organization actively engages in strategic collaborations with companies such as AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., Ridgeback Biotherapeutics, and Gilead Sciences, Inc. These partnerships are specifically aimed at the joint development and commercialization of prolonged-acting therapies for HIV. Established in 1891, Merck & Co., Inc. maintains its corporate headquarters in Kenilworth, New Jersey.
주가
$152.40
시가총액
$376.40B
변동 (1일)
12.48%
변동 (1년)
79.44%
국가
US
거래 Merck & Co., Inc. (MRK)

카테고리

Merck & Co., Inc. (MRK)의 영업이익률
August 2026 기준 영업이익률 TTM: 16.65%
Merck & Co., Inc.의 최신 재무 보고서와 주가에 따르면 현재 영업이익률 (TTM)은 16.65%입니다. 2024년 말 기준 영업이익률은 31.51%였습니다.
Merck & Co., Inc.의 영업이익률 기록 (2000 ~ 2026)
매년 말 영업이익률
연도 영업이익률 변화
2026 (TTM) 16.65% -59.58%
2025 41.19% 30.72%
2024 31.51% 541.75%
2023 4.91% -84.08%
2022 30.84% 13.80%
2021 27.10% 102.84%
2020 13.36% -34.06%
2019 20.26% -4.07%
2018 21.12% 24.68%
2017 16.94% 22.66%
2016 13.81% -27.73%
2015 19.11% 20.80%
2014 15.82% -9.13%
2013 17.41% -16.70%
2012 20.90% 11.88%
2011 18.68% 155.89%
2010 7.30% -50.20%
2009 14.66% -42.53%
2008 25.51% 9.86%
2007 23.22% 42.54%
2006 16.29% -38.81%
2005 26.62% -9.52%
2004 29.42% -22.80%
2003 38.11% -10.08%
2002 42.38% -3.18%
2001 43.77% 94.36%
2000 22.52% 0.00%
유사 기업 또는 경쟁사의 영업이익률
회사 영업이익률 영업이익률 차이 국가
43.92% -97.36%
US
26.81% -98.39%
US
29.32% -98.24%
US
26.59% -98.40%
CH
31.24% -98.12%
CH
회사의 영업이익률이란?
영업이익률은 회사의 수익성을 평가하는 핵심 지표입니다. 높은 영업이익률은 일반적으로 긍정적으로 간주되며, 이는 회사가 제품이나 서비스를 생산 비용보다 훨씬 높은 가격에 판매할 수 있음을 보여줍니다. 영업이익률은 회사의 수익을 매출로 나누어 계산합니다.